The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

Category: Pharma & Human Health

Toward Clinical Utility of Metagenomic Data: Interview with Dr Joël Doré
Editor's Choice

Toward Clinical Utility of Metagenomic Data: Interview with Dr Joël Doré

OCT 17, 2019
Azitra Completes $14 Million Series A Financing
Finance

Azitra Completes $14 Million Series A Financing

OCT 16, 2019
5-minute Microbiome Science Roundup: September 2019
Editor's Choice

5-minute Microbiome Science Roundup: September 2019

OCT 16, 2019
BiomeSense Raises $2 Million in Seed Round Funding
Finance

BiomeSense Raises $2 Million in Seed Round Funding

OCT 11, 2019
Seventure Partners Life Sciences Corporate Update Health for Life: July 2019 – September 2019
Animal Health

Seventure Partners Life Sciences Corporate Update Health for Life: July 2019 – September 2019

OCT 10, 2019
Gut bacteria ‘fingerprint’ predicts radiotherapy side effects
Gastrointestinal

Gut bacteria ‘fingerprint’ predicts radiotherapy side effects

OCT 9, 2019
ORNL scientists shed light on microbial ‘dark matter’ with new approach
Pharma & Human Health

ORNL scientists shed light on microbial ‘dark matter’ with new approach

OCT 8, 2019
BASF and Biomillenia join forces in microbiome research to promote healthy skin
Finance

BASF and Biomillenia join forces in microbiome research to promote healthy skin

OCT 8, 2019
4D Pharma collaborates with MSD to develop Live Biotherapeutics for vaccines
Finance

4D Pharma collaborates with MSD to develop Live Biotherapeutics for vaccines

OCT 8, 2019
Researchers unlock potential to use CRISPR to alter the microbiome
GMO & Synbio

Researchers unlock potential to use CRISPR to alter the microbiome

OCT 8, 2019
Bacteria can be used to heal aspirin-induced ulcers: Irish research reveals
Pharma & Human Health

Bacteria can be used to heal aspirin-induced ulcers: Irish research reveals

OCT 7, 2019